Frequency and types of human papillomavirus among pregnant and non-pregnant women with human immunodeficiency virus infection in Recife determined by genotyping

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 5, 2009, Pages 755-763

  Brandao, Virginia ^a,b,c   Lacerda, Heloisa Ramos ^b,d   Lucena Silva, Norma ^e,f   Ximenes, Ricardo Arraes de Alencar ^b,d  

^a Centro Integrado de Saúde Amaury de Medeiros CISAM   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Departamento de Patologia   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

Author keywords

Human immunodeficiency virus; Human papillomavirus; Polymerase chain reaction; Pregnancy; Squamous intraepithelial lesion

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 70350042211     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000500016     Document Type: Article

References (72)

1. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ 2004. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 96: 1070-1076.
2. Arbyn M, Sasieni P, Meijer CJLM, Claved C, Koliopoulos G, Dillner J 2006. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24 (Suppl. 3): S78-89.
3. Armbruster-Moraes E, Toshimoto LM, Leão E, Zugaib M 2000. Prevalence of "high risk" human papillomavirus in the lower genital tract of Brazilian gravidas. Int J Gynaecol Obstet 69: 223-227.
4. Berek JS 2003. Simplification of the New Bethesda 2001. Classification system. Am J Obstet Gynecol 188: 2-5.
5. Berrébi A, Badiou W, Duclusaud A 2008. Frequency, persistence and recurrence of HPV lesions of the uterine cervix in HIV-positive women. Gynecol Obstet Fertil 36: 521-524.
6. Bollen LJM, Chuachoowong R, Kilmarx PH, Mappstats PAM, Culnane M, Skunodom N, Chaowanachan T, Jetswang B, Neeyapun K, Asavapiriyanont S, Roongpisuthipong A, Wright TC, Tappero JW 2006. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implica-tion for future HPV immunization. Sex Transm Dis 33: 259-264.
7. Brandão VCRAB 2008. Fatores de risco para lesões intra-epiteliais cervicais, freqüência e tipos de papilomavírus (HPV) em gestantes infectadas pelo vírus da imunodeficiência humana (HIV), PhD Thesis, Universidade Federal de Pernambuco, Recife, 148 pp.
8. Câmara GNL, Cerqueira DM, Oliveira APG, Silva EO, Carvalho LGS, Martins CRF 2003. Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz 98: 879-883.
9. Campos RR, Melo VH, Castilho DM, Nogueira CPF 2005. Prevalência do papilomavírus humano e seus genótipos em mulheres portadoras e não-portadoras do vírus da imunodeficiência humana. RBGO 27: 248-256.
10. Castellsague X, Muñoz N 2003. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives and tobacco smoking. J Natl Cancer Inst Monogr 31: 20-28.
11. Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A 2002. Restricted crossreactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 11: 1394-1399.
12. Chan PK, Li WH, Chan MYM, Ma WL, Cheung LK, Cheng AF 1999. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol 59: 232-238.
13. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarela S, Anh PTH, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, Sanjosé S de, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJLM, Franceschi S 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366: 991-998.
14. + e de carga viral em pacientes HIVsoropositivas. RBGO 26: 97-102.
15. Correia HS, Cornetta MCM, Gonçalves AKS 2006. Infecção genital pelo papilomavírus humano (HPV) em mulheres grávidas. Rev Brasil de Genit 1: 14-19.
16. Costa KCBC, Pereyra EAG, Zugaib M 2000. Infecção pelo HPV durante o ciclo gravídico-puerperal. RBGO 11: 62-64.
17. De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N 2008. Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of highrisk human papillomavirus in women with abnormal PAP smear. J Virol Methods 147: 10-17.
18. Denny L, Boa R, Williamson AL, Allan B, Hardie D, Stan R, Myer L 2008. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol 111: 1380-1387.
19. Di Felice V, David S, Cappello F, Farina F, Zummo G 2005. Is chlamydial heat shock protein 60 a risk factor for oncogenesis? Cell Mol Life Sci 62: 4-9.
20. Dillner J 2001. Primary screening for human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol 15: 743-757.
21. Duerr A, Kieke B, Warrend Shah K, Burk R, Peipert JF 2001. Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol 184: 584-590.
22. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC 2000. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283: 1031-1037.
23. Ferenczy A, Coutlée F, Franco E, Hankins C 2003. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ 169: 431-434.
24. Fernandes AP, Gonçalves MAG, Simões RT, Quintana SM, Duarte G, Donadi EA 2004. Influência da infecção pelo HIV-1 sobre a presença do HPV em lesões do colo uterino. DST J Bras Doenças Sex Trans 161: 21-25.
25. Harris TB, Kulasingam SL, Kiviat NB, Mao C, Agoff SN, Feng Q, Koutsky LA 2004. Cigarette smoking, oncogenic human papillomavirus, KI-67 antigen and cervical intraepithelial neoplasia. Am J Epidemiol 159: 834-842.
26. Hawes SE, Critchlow CW, Sow PS, Tourép N, Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB 2006. Incident high-grade sqamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1(HIV-1) and HIV-2. J Natl Cancer Inst 98: 105-109.
27. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine D 1998. Early regression of lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 12: 1459-1464.
28. Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, Melnick S, Abulafia O, Levine AM, WIHS Collaborative Study Group 2004. Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr 36: 978-985.
29. Ho CM, Yang SS, Chien TS, Huang SH, Jeng CJ, Chang SF 2005. Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients. Gynecol Oncol 99: 615-621.
30. IARC - International Agency for Research on Cancer 2007. Monographs on the evaluation of carcinogenic risks to humans, vol. 90, IARC, Lyon, 671 pp.
31. Jamieson DJ, Duerr A, Burk R, Klein RS, Paramsothy P, Schuman P 2002. Characterization of genital human papillomavirus infec in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol 186: 21-27.
32. Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E 2007. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol 104: 232-246.
33. Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, Pannuti CS 2004. Presence of multiple human papilloma virus type in cervical samples from HIV-infected women. Gynecol Oncol 92: 225-231.
34. Levi JE, Fink MS, Canto CLM, Carretiero N, Matsubara R, Linhares I, Dolores GB, Castelo A, Segurado A, Uip D, Eluf Neto J 2002. Human papillomavirus prevalence, viral load and cervical intraepithelial neoplasia in HIV-infected women. Braz J Infect Dis 6: 129-135.
35. Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A, Uberti-Foppa C 2005. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis 40: 451-457.
36. Lin H, Ma Y, Moh J, Ou Y, Shen S, Chang Chien C 2006. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 101: 40-45. cofactors. Int J Cancer 120: 650-655.
37. Madeleine MM, Anttila T, Schwartz SM, Saikku P, Leinonen M, Carter JJ 2007. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120: 650-655.
38. Mammas IN, Vageli D, Spandidos DA 2008. Geographic variations of human papilloma virus infection and their possible impact on the effectiveness of the vaccination programme. Oncol Rep 20: 141-145.
39. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wollinsky SM 1989. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7: 209-214.
40. Meisels SJ 1992. Doing harm by doing good: iatrogenic effects of early childhood enrollment and promotion policies. Early Child Res Q 7: 155-175.
41. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, Muderspach L, Burk R, Palefsky J 2001. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15: 2157-2164.
42. Minkoff H, Lin SX, Watts DH, Leighty R, Hershow R, Palefsky J, Tuomala R, Neu N, Zorrilla CD, Paul M, Strickler H 2006. Relationship of pregnancy to human papillomavirus among human immunodeficiency vírus-infected women. Obst Gynecol 108: 953-960.
43. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S 2002. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 359: 1085-1092.
44. Mota GR 2002. Avaliação da infecção e caracterização de tipos de papilomavírus humano (HPV) em gestantes infectadas pelo vírus da imunodeficiência humana (HIV-1), PhD Thesis, Escola Paulista de Medicina, São Paulo, 89 pp.
45. MS - Ministério da Saúde 2005. Coordenação Nacional de DST/AIDS. Manual de controle das doenças sexualmente transmissíveis, 4a ed., MS, Brasília, 142 pp.
46. Muñoz N, Bosch FX, Sanjosé S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ 2003. Epidemiologic classification of human papilloma virus types associated with cervical cancer. N Engl J Med 345: 518-527.
47. Muñoz N, Castellsague X, de González AB, Grissmann L 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24: S1-10.
48. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shan KV, Meijer CJ, Bosch FX 2002. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric casecontrol study. Lancet 359: 1093-1101.
49. Nappi L, Carriero C, Bettocchi S, Herrero J, Vimercati A, Pano G 2005. Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence and progression, in treated and untreated women. Eur J Obstet Gynecol Reprod Biol 121: 226-232.
50. Nicol AF, Feranades ATG, Bonecini-Almeida MG 2005. Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection A Review. Mem Inst Oswaldo Cruz 100: 1-12.
51. Palefsky J 2006. Human papillomavirus-related tumors in HIV. Curr Opin Oncol 18: 463-468.
52. Parham GP, Sarasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH 2006. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 103: 1017-1022.
53. Pereira CRN, Rosa MLG, Vasconcelos GALBM, Faria PCP, Cavalcanti SMB, Oliveira LHS 2007. Human papillomavirus preva-lence and predictors for cervical cancer among high-risk women from Rio de Janeiro. Int J Gynecol Cancer 17: 651-660.
54. Puig-Tintoré LM, Menendez AA, Bordoy XC, Bosch FX, Bladé AT, Castellsague X 2002. La infección por papilomavirus, Documentos de consenso, SEGO, Barcelona, 56 pp.
55. Queiroz C, Travassos AG, Studart E, Araújo Filho JB, Sarno CK, Pinheiro CC 2004. Prevalence of human papilloma virus in HIVpositive and HIV-negative patients in the state of Bahia. A pilot study. Braz J Infect Dis 8: 356-362.
56. Rabelo-Santos SH, Zeferino L, Villa LL, Sobrinho JP, Amaral RG, Magalhães AV 2003. Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiânia, Brazil. Mem Inst Oswaldo Cruz 98: 181-184.
57. Rando RF, Lindheim S, Hasty L, Sedlacek TV, Woodland M, Eder C 1989. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 161: 50-55.
58. Santegoets LA, van Seters M, Heijmans-Antonissen C, Kleinjan A, van Beurden M, Ewing PC, Kühne LC, Beckmann I, Burger CW, Helmerhorst TJ, Blok LJ 2008. Reduced local immunity in HPVrelated VIN: expression of chemokines and involvement of immunocompetent cells. Int J Cancer 123: 616-622.
59. Schneider A, Hotz M, Gissmann L 1987. Increased prevalence of human papillomavirus in the lower genital tract of pregnant women. Int J Cancer 40: 198-201.
60. Silva RJ, Athayde MJPM, Pedrosa ML, Fialho SCAV, Russomano FB, Grinsztejn B, Silva LGP 2005. Lesões intra-epiteliais vulvares em pacientes infectadas pelo HIV. RBGO 27: 407-414.
61. Silva TT 2004. Fatores de risco para neoplasia intra-epitelial cervical em pacientes submetidas à avaliação morfológica e pesquisa de DNA/HPV, PHD Thesis, Universidade Federal de Pernambuco, Recife, 130 pp.
62. Sun XW, Kuhn L, Ellenbrock TV, Chiasson MA, Bush TJ, Wright TC 1997. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337: 1343-1349.
63. Trotier H, Franco EL 2006. The epidemiology of genital human papillomavirus infection. Vaccine 24 (Suppl. 1): S1-15.
64. Villa LL, Denny L 2006. Methods for detection of HPV infection and its clinical utility. Int J Gynaecol Obstet 94: S71-80.
65. Wagner TM, Pezzotti P, Valdarchi C, Rezza G 2001. Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 26: 394-395.
66. Walker P, Dexeus S, De Palo G, Barrasso R, Campion M, Girardi F, Jacob C, Roy M 2003. International terminology of colposcopy: an update report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 101: 175-177.
67. Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller JT, Garnett GP, Meheus A 2006. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from 2006 workshop of international experts. Vaccine 24: S251-261.
68. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW 1994. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolau smears. Obstet Gynecol 84: 591-597.
69. Welkovic S 2007. Células de Langerhans em mulheres HIV-soropositivas com neoplasia intraepitelial cervical, PHD Thesis, Universidade Federal de Pernambuco, Recife, 132 pp.
70. Yokoyama M, Iwasaka T, Nagata C, Nozawa S, Sekiya S, Hirai Y, Kanazawa K, Sato S, Hoshiai H, Sugase M, Kawana T, Yoshikawa H 2003. Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan. Cancer Lett 192: 171-179.
71. Zerbini M, Venturoli S, Cricca M, Gallinella G, De Simone P, Costa S, Santini D, Musiani M 2001. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCRELISA. J Clin Pathol 54: 377-380.
72. Zimmermmann JB, Melo VH, Castro PF, Alves MJM, Zimmermmann SG, Del Castillo DM 2006. Associação entre a contagem de linfócitos T CD4 e a gravidade da neoplasia intra-epitelial cervical diagnosticada pela histopatologia em mulheres infectadas pelo HIV. RBGO 28: 345-351.